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Abstract
Background: Citrullinemia type II is an autosomal recessive urea cycle disorder and a subtype of citrin deficiency.
However, the management of recurrent hyperammonemia with neurologic symptoms in patients with citrullinemia
type II is quite different from the management of other types of urea cycle disorders. In pats with citrullinemia type
II, regional anesthesia might be a good choice for the early detection of hyperammonemic symptoms and
addressing psychic stress.
Case presentation: A 48-year-old male with adult onset citrullinemia type II was scheduled for urethral scrotal
fistula repair. During the first operation, spinal anesthesia with conscious sedation using dexmedetomidine was
used, a second operation was performed after confirmation of infection control and a stable neurologic condition.
In this patient, dietary planning with close monitoring of serum ammonia level and close observation of neurologic
conditions might lead to successful perioperative care.
Conclusion: For anesthesia of patients with adult onset citrullinemia type II, close monitoring of neurologic signs
and serum ammonia are important to reduce neurologic complications induced by hyperammonemia. Regional
anesthesia with a proper dietary plan might reduce patient stress and prevent metabolic tragedy.
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Background
Citrullinemia type II is a subtype of citrin deficiency, and is
an autosomal recessive urea cycle disorder characterized by
recurrent uncompensated hyperammonemia with neuro-
logic symptoms. Although the majority of urea cycle disor-
ders are diagnosed during the neonatal period, citrullinemia
type II manifests in children and adults [1]. This rare
disease is related to the SLC25A13 pathogenic variant, and
causes a liver-specific argininosuccinate synthetase defi-
ciency [2]. Although serum ammonia levels are not consist-
ent with clinical symptoms, hyperammonemia can lead to
cerebral edema and neurologic injury [3], and thus,
perioperative monitoring of serum ammonia levels and
aggressive management to reduce serum ammonia levels
are important.
Hyperammonemic crisis in patients with urea cyclic
disorder can be provoked by infection, fever, preoperative
fasting, surgery, or general anesthesia, which are
commonly encountered during the perioperative period
[4]. Moreover, the management of hyperammonemic en-
cephalopathy in patients with citrullinemia type II differs
substantially from what is required to treat other classic
urea cycle disorders. In particular, the low protein diets
and high amounts of carbohydrate normally provided as
emergency regimens to patients with other urea cycle
disorder are associated with risks in citrullinemia type II
patients [5, 6], and thus, strict dietary planning is an
important aspect of perioperative management.
No previous report has been issued in the English litera-
ture on anesthetic experience of an adult patient with
citrullinemia type II. Here, we describe our experience and
perioperative care of a patient with recurrent hyperammo-
nemic encephalopathy related to citrullinemia type II.
Case presentation
A 48-year-old male (178 cm, 60 kg, body mass index
18.9 kg/m2) was scheduled for urethral scrotal fistula
repair. He had been diagnosed with anxiety disorder,
imprisoned for illegal drug use, and diagnosed some
15 years previously with hepatitis C. Ten years before
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visiting our hospital, he experienced a mental status
change, was hyperammonemic, but with normal liver
function, and was diagnosed with citrullinemia type II
based on biochemical assay results. He had never experi-
enced ascites or esophageal varix, but had experienced re-
current uncompensated hyperammonemia, for which he
was taking arginine and sodium benzoate. Prior to transfer
to our hospital, he had been living in a sanatorium in a bed
ridden state with slurred speech and motor weakness.
Subsequent brain computed tomography demonstrated
progressive diffuse brain atropy.
The patient was admitted to our urology department for
urethral fistula repair and cystolitholapaxy. Preoperative
electrocardiographic and chest x-ray findings were nor-
mal, and pre- and post-operative serum ammonia levels
were illustrated in Fig. 1 (normal value 12-66 μg/dL).
Serum ammonia level fluctuations were controlled by
daily lactulose enema and intravenous arginine and so-
dium benzoate. The medical team involved prescribed a
1000 kcal/day diet with a PFC ratio of 14 %:27 %:59 %.
Preoperatively, his blood pressure was 100/50 mm Hg,
heart rate 88 beats/min, and body temperature 39.3 °C,
and he had a scrotal abscess. His preoperative laboratory
data were as follows: hematocrit 31.3 %, platelet count
161 × 103/ml, blood urea nitrogen (BUN) 10.4 mg/dl, cre-
atinine (Cr) 0.5 mg/dl, prothrombin time (PT) 14.5 sec
(INR 1.34), activated partial thromboplastin time (aPTT)
38.5 sec, serum albumin 2.4 g/dl, aspartate aminotransfer-
ase 88 IU/L, alanine aminotransferase 43 IU/L, total
bilirubin 0.5 mg/dl, direct bilirubin 0.32 mg/dl, and serum
gamma-glutamyl transferase 349 IU/L, the latter of which
was moderately elevated (normal 0-72U/L).
Surgery was performed 5 days after admission. He was
not administered premedication and in the operating
theatre his vital signs were monitored by pulse-oximetry,
ECG, and a non-invasive blood pressure device. Spinal
anesthesia was performed using 12 mg of 0.5 % hyper-
baric bupivacaine using a 25-gauge Quinke needle to
block the T6 thoracic level. Dexmedetomidine was ad-
ministered for sedation during surgery. Plasma solution
(600 ml; sodium chloride 5.26 g, sodium gluconate
5.02 g, sodium acetate hydrate 3.68 g, potassium chlor-
ide 0.37 g, and magnesium chloride 0.3 g per liter;
Plasma solution A inj., CJ Health Care, Korea) was
infused during the 120 min operation, which involved
open cystolitholapaxy, fistula repair, and removal of
the abscess pocket, and estimated blood loss was
100 ml. No adverse event occurred during surgery.
The surgical team planned a second-look operation
after fever control had been achieved and confirmed
the absence of bacterial growth in the surgical wound.
No neurologic events of significance occurred before
the second operation despite poorly controlled serum
ammonia levels.
Twenty days after the first operation, while still hospi-
talized, the patient underwent a second operation under
spinal anesthesia (T8 with 12 mg of 0.5 % hyperbaric
bupivacaine) for wound repair and cystoscopic examin-
ation; 0.9 % normal saline was used as distension
medium during the cystoscopic examination. During the
60 min operation, 400 ml of plasma solution was in-
fused. The patient did not experience any change in con-
sciousness level, despite fluctuating serum ammonia
levels, during his 43-day hospital stay.
Fig. 1 Perioperative serum ammonia level changes
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Conclusion
Citrullinemia type II is an inherited metabolic disease
that has been reported to have an incidence of 1 per
100,000 of the population in Japan and to be rare in
America and Europe [1]. Under stressful medical or
surgical conditions hyperammonemic symptoms can
develop even in patients with no previous diagnosis of
citrullinemia type II [7].
This condition is caused by a mutation in the
SLC25A13 gene, which encodes citrin transporter, that
can interfere with glycolysis, the urea cycle, gluconeo-
genesis, and galactose metabolism [1]. The clinical fea-
tures of citrullinemia type II are hyperammonemia,
neuropsychiatric symptoms, and hepatic dysfunction.
Furthermore, more than 90 % of citrullinemia type II
patients have a body mass index of < 20 kg/m2 [2, 8].
Unlike other urea cycle disorders, which are diagnosed
during the neonatal period, citrullinemia type II occurs
suddenly between the ages of 11 and 79 years [1]. Our
patient had typical signs and symptoms of citrullinemia
type II, that is, a history of anxiety disorder, neurologic
symptoms, such as, motor dysfunction and slurred
speech, a body mass index of 18.9 kg/m2, a diagnosis in
adulthood, and recurrent hyperammonemic episodes in
addition to inactive hepatitis C.
Alcohol intake or) stressful medical or surgical condi-
tions can trigger hyperammonemic crisis in citrullinemia
type II patients, and this can lead to life threatening
events, such as, brain injury or even death [1, 7]. How-
ever, to the best of our knowledge, no report has been
issued on perioperative concerns regarding patients with
adult onset citrullinemia type II.
In our patient, a perioperative hyperammonemic event
could have mimicked delayed emergence from general
anesthesia [9, 10], Also, hypotonic, nonconductive, low-
viscosity fluids like glycin might improve visualization
during cystoscopy but present the risk of hyperammone-
mia, electrolyte disturbances, such as, extreme hypona-
tremia or brain edema. Furthermore, the absorption of
distension media can cause headache, anxiety, confusion,
seizures, and death, which are also the symptoms of
hyperammonemic crisis [11, 12]. In fact, the early detec-
tion of extreme absorption of distension media or a
hyperammonemic event is critical for early treatment.
We selected spinal anesthesia to enable changes in men-
tality to be checked during surgeries and dexmedetomi-
dine as a sedative, because of its suitability for conscious
sedation [13]. Furthermore, normal saline was used as a
distension media during cystoscopy.
Mots urea cycle disorders require low protein, high
carbohydrate diets to reduce ammonia production, but
citrullinemia type II requires a quite different diet plan.
Because citrullinemia type II is caused by defective aspar-
tate export from mitochondria to cytosol, the cytosolic
nicotinamide adenine dinucleotide to oxidized nicotina-
mide adenine dinucleotide ratio (NAHD/NAD+) can in-
crease abnormally, inhibit glycolysis, and caused difficulties
associated with the metabolism of alcohol [2, 14], which is
why patients with citrullinemia type II prefer diets rich in
aspartate and asparagine, such as, beans and peanuts. High
carbohydrate intake increases NADH/NAD+ ratio and
disturbs ureagenesis by restricting aspartate supply to the
urea cycle, resulting in severe hyperammonemia, and thus,
PFC ratios of greater than 60 % should be avoided in citrul-
linemia type II patients [14]. For our patient, we recom-
mended a PFC ratio of 14 %:27 %:59 %, restricted calories
(in view of his bed-ridden state), and no glucose solution
infusion.
Summarizing, for the anesthesia of patients with adult
onset citrullinemia type II, changes in neurologic signs
and the monitoring of serum ammonia are important
for reducing hyperammonemia-induced neurologic com-
plications. Given a well thought out plan for reducing
stressful surgical conditions, dietary care should not be
overlooked. Furthermore, regional anesthesia with
proper sedation is probably be a good choice for the
early detection of hyperammonemic symptoms and for
the differential diagnosis of excess absorption of disten-
tion media in citrullinemia type II patients undergoing
an urologic procedure.
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